The US Food and Drug Administration (FDA) is requiring all patients with a fat-loss surgery to undergo a fat burn assessment and a fat burning assessment, or FBA, according to a new report.
The FBA assesses a patient’s overall physical condition, which may include physical fitness, muscle strength, or muscular strength.
If the patient does not meet the FBA criteria, the patient can be denied surgery.
The FDA says that patients must receive a fat burner assessment, which measures fat loss in a specific body part, which can include waist circumference, body mass index, waist/hip ratio, or waist circumference/hip ratios.
The assessment is conducted at least two months after surgery, according the report.
The FDA says patients with diabetes, heart disease, and hypertension are excluded from the study.
The FDA also requires patients to undergo “stress testing,” which involves physical and mental activities in order to determine if the patient has developed stress reactions related to the surgery.
The report also states that the patient must not have any health issues or complications related to surgery for a few months after the procedure, or for one year after surgery.
As for the patients who have not completed the FBE assessment, the FDA says the patient should receive counseling and support services, including mental health counseling, medication, and diet counseling.
The latest FBA guidelines were released last week by the American Society for Gastroenterology and Hepatology (ASGHE), a leading body in the field of obesity and dietetics.